(Q85223195)
Statements
Depletion of naïve lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity (English)
Nadir Askenasy
Keren Mizrahi
Shifra Ash
Enosh M Askenasy
Isaac Yaniv
16 October 2012